Wave Life Sciences Shares Drop After Equity Offering Prices

Dow Jones12-10

By Robb M. Stewart

Wave Life Sciences' shares fell sharply after the clinical-stage biotechnology company priced an upsized $350 million equity raising.

The shares were down 10% at $19.09 in early trading Wednesday, narrowing the advance in 2025 to 54%.

Wave Life late Tuesday said an underwritten public offering of 15.8 million of its shares was priced at $19 apiece, along with warrants to buy 2.63 million shares at $18.9999 each.

The company granted the underwriters a 30-day option to buy up to an additional 2.76 million of its shares on the same terms.

Wave Life on Monday launched an offering of $250 million of its shares and warrants.

The offering is expected to close on or about Thursday.

Write to Robb M. Stewart at robb.stewart@wsj.com

(END) Dow Jones Newswires

December 10, 2025 09:52 ET (14:52 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2590095533?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-10 22:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590095533","market":"sh","top_or_hot":-1,"title":"Wave Life Sciences Shares Drop After Equity Offering Prices","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Robb M. Stewart \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/WVE\">Wave Life</a> Sciences' shares fell sharply after the clinical-stage biotechnology company priced an upsized $350 million equity raising. \n</p>\n<p>\n  The shares were down 10% at $19.09 in early trading Wednesday, narrowing the advance in 2025 to 54%. \n</p>\n<p>\n  Wave Life late Tuesday said an underwritten public offering of 15.8 million of its shares was priced at $19 apiece, along with warrants to buy 2.63 million shares at $18.9999 each. \n</p>\n<p>\n  The company granted the underwriters a 30-day option to buy up to an additional 2.76 million of its shares on the same terms. \n</p>\n<p>\n  Wave Life on Monday launched an offering of $250 million of its shares and warrants. \n</p>\n<p>\n  The offering is expected to close on or about Thursday. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Robb M. Stewart at robb.stewart@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 10, 2025 09:52 ET (14:52 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wave Life Sciences Shares Drop After Equity Offering Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWave Life Sciences Shares Drop After Equity Offering Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-12-10 22:52</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Robb M. Stewart \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/WVE\">Wave Life</a> Sciences' shares fell sharply after the clinical-stage biotechnology company priced an upsized $350 million equity raising. \n</p>\n<p>\n  The shares were down 10% at $19.09 in early trading Wednesday, narrowing the advance in 2025 to 54%. \n</p>\n<p>\n  Wave Life late Tuesday said an underwritten public offering of 15.8 million of its shares was priced at $19 apiece, along with warrants to buy 2.63 million shares at $18.9999 each. \n</p>\n<p>\n  The company granted the underwriters a 30-day option to buy up to an additional 2.76 million of its shares on the same terms. \n</p>\n<p>\n  Wave Life on Monday launched an offering of $250 million of its shares and warrants. \n</p>\n<p>\n  The offering is expected to close on or about Thursday. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Robb M. Stewart at robb.stewart@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 10, 2025 09:52 ET (14:52 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2590095533","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590095533","pubTimestamp":1765378320,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Wave Life Sciences' shares fell sharply after the clinical-stage biotechnology company priced an upsized $350 million equity raising.The shares were down 10% at $19.09 in early trading Wednesday, narrowing the advance in 2025 to 54%.Wave Life late Tuesday said an underwritten public offering of 15.8 million of its shares was priced at $19 apiece, along with warrants to buy 2.63 million shares at $18.9999 each.The company granted the underwriters a 30-day option to buy up to an additional 2.76 million of its shares on the same terms.Wave Life on Monday launched an offering of $250 million of its shares and warrants.The offering is expected to close on or about Thursday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","WVE":"Wave Life Sciences Pte. Ltd","EQR":"资产住宅公司","BK4007":"制药","BK4215":"住宅房地产投资信托","BK4588":"碎股"},"translate_title":"Wave Life Sciences股价在股票发行价格后下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WVE":0.9,"EQR":1.5},"content_text":"By Robb M. Stewart \n\n\n \n\n\nWave Life Sciences' shares fell sharply after the clinical-stage biotechnology company priced an upsized $350 million equity raising. \n\n\n  The shares were down 10% at $19.09 in early trading Wednesday, narrowing the advance in 2025 to 54%. \n\n\n  Wave Life late Tuesday said an underwritten public offering of 15.8 million of its shares was priced at $19 apiece, along with warrants to buy 2.63 million shares at $18.9999 each. \n\n\n  The company granted the underwriters a 30-day option to buy up to an additional 2.76 million of its shares on the same terms. \n\n\n  Wave Life on Monday launched an offering of $250 million of its shares and warrants. \n\n\n  The offering is expected to close on or about Thursday. \n\n\n \n\n\n  Write to Robb M. Stewart at robb.stewart@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 10, 2025 09:52 ET (14:52 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2590095533","isCrawlerRequest":true}